FRANKFURT—Shares in Germany’s Bayer’s fell more than 12 percent on March 20 after a second U.S. jury ruled its Roundup weed killer caused cancer.
The March 19 unanimous jury decision in San Francisco federal court was not a finding of Bayer’s liability for the cancer of plaintiff Edwin Hardeman. Liability and damages will be decided by the same jury in a second trial phase beginning on March 20.
